Naproxen Sodium Diphenhydramine Hcl Tablet, Film Coated
NDC Package 69842-328-08
Package Information
Naproxen Sodium Diphenhydramine Hcl tablets is • do not take more than directed • drink a full glass of water with each dose • adults and children 12 years and over: take 2 caplets at bedtime • do not take more than 2 caplets in 24 hours • if taken with food, this product may take longer to work. This formulation utilizes a tablet, film coated delivery system. Marketed by Cvs Pharmacy, Inc, this product is identified by NDC 69842-328 and is authorized under FDA application ANDA213663.
Identification & Billing
- RxCUI: 1550957 - diphenhydrAMINE HCl 25 MG / naproxen sodium 220 MG Oral Tablet
- RxCUI: 1550957 - diphenhydramine hydrochloride 25 MG / naproxen sodium 220 MG Oral Tablet
Clinical Specifications
- Anti-Inflammatory Agents, Non-Steroidal - [CS]
- Cyclooxygenase Inhibitors - [MoA] (Mechanism of Action)
- Histamine H1 Receptor Antagonists - [MoA] (Mechanism of Action)
- Histamine-1 Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Nonsteroidal Anti-inflammatory Drug - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 69842 - Cvs Pharmacy, Inc
- 69842-328 - Naproxen Sodium Diphenhydramine Hcl
- 69842-328-08 - 80 TABLET, FILM COATED in 1 BOTTLE
- 69842-328 - Naproxen Sodium Diphenhydramine Hcl
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (69842-328). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 69842-328-08 identifies a specific commercial package of 80 tablet, film coated in 1 bottle of Naproxen Sodium Diphenhydramine Hcl, a human over the counter drug labeled by Cvs Pharmacy, Inc. This tablet, film coated is formulated for oral use and contains diphenhydramine hydrochloride; naproxen sodium as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cvs Pharmacy, Inc on May 14, 2021. The current certification is valid through December 31, 2026.
How is this Cvs Pharmacy, Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 69842032808. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.